TCF7L2基因rs7903146变异通过损害β细胞功能和肝脏胰岛素敏感性增加肥胖青少年糖尿病前期/2型糖尿病风险
研究在955名多种族肥胖青少年中检测TCF7L2 rs7903146变异,用口服葡萄糖耐量试验及口服最小模型评估胰岛素分泌,33人行高胰岛素-正血糖钳夹,307人在3.11±2.36年后重复口服葡萄糖耐量试验。风险等位基因与白种人和非裔美国人2小时血糖升高相关,与β细胞反应性降低和糖耐量受损相关,肝脏内生葡萄糖生成抑制减弱,随访时糖耐量受损/2型糖尿病风险增加(OR 2.224;95%CI 1.370-3.612;P=0.0012)。
要点
- TCF7L2 rs7903146风险等位基因与白种人和非裔美国人2小时血糖升高相关,西班牙裔仅见趋势。
- 风险等位基因与β细胞反应性降低和糖耐量受损相关(P<0.05)。
- 携带风险变异者随访时糖耐量受损/2型糖尿病风险增加(OR 2.224;95%CI 1.370-3.612;P=0.0012)。
核心结论
- TCF7L2 rs7903146变异通过损害β细胞功能增加肥胖青少年糖耐量受损/2型糖尿病风险,肝脏胰岛素敏感性可随时间预测糖耐量受损/2型糖尿病的发展。
研究设计与样本
- 在955名多种族青少年队列中对TCF7L2 rs7903146变异进行基因分型,所有受试者行口服葡萄糖耐量试验并用口服最小模型评估胰岛素分泌,33人行高胰岛素-正血糖钳夹。
- 307名受试者在3.11±2.36年后重复口服葡萄糖耐量试验。
主要发现
- TCF7L2 rs7903146风险等位基因与白种人2小时血糖升高相关(P=0.006),与非裔美国人2小时血糖升高相关(P=0.009),西班牙裔仅见趋势(P=0.072)。
- T等位基因与β细胞反应性降低和糖耐量受损相关(P<0.05)。
- 携带风险变异者肝脏内生葡萄糖生成的抑制较低(P=0.006)。
- 随访时携带次要等位基因者糖耐量受损/2型糖尿病的比值比更高(OR 2.224;95%CI 1.370-3.612;P=0.0012)。
关键数值与推荐
- 风险等位基因与白种人2小时血糖升高相关(P=0.006),与非裔美国人相关(P=0.009),西班牙裔趋势(P=0.072)。
- T等位基因与β细胞反应性降低和糖耐量受损相关(P<0.05)。
- 风险变异者肝脏内生葡萄糖生成抑制较低(P=0.006)。
- 随访时糖耐量受损/2型糖尿病比值比(OR 2.224;95%CI 1.370-3.612;P=0.0012)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In this study, we aimed to explore the mechanism by which TCF7L2 rs7903146 risk allele confers susceptibility to impaired glucose tolerance (IGT) or type 2 diabetes (T2D) in obese adolescents. RESEARCH DESIGN AND METHODS: The rs7903146 variant in the TCF7L2 gene was genotyped in a multiethnic cohort of 955 youths. All subjects underwent an oral glucose tolerance test with the use of the Oral Minimal Model to assess insulin secretion, and 33 subjects underwent a hyperinsulinemic-euglycemic clamp. In 307 subjects, a follow-up oral glucose tolerance test was repeated after 3.11 ± 2.36 years. RESULTS: The TCF7L2 rs7903146 risk allele was associated with higher 2-h glucose levels in Caucasians (P = 0.006) and African Americans (P = 0.009), and a trend was seen also in Hispanics (P = 0.072). Also, the T allele was associated with decreased β-cell responsivity and IGT (P < 0.05). Suppression of endogenous hepatic glucose production was lower in subjects with the risk variant (P = 0.006). Finally, the odds of showing IGT/T2D at follow-up were higher in subjects carrying the minor allele (odds ratio 2.224; 95% CI 1.370-3.612; P = 0.0012). CONCLUSIONS: The rs7903146 variant in the TCF7L2 gene increases the risk of IGT/T2D in obese adolescents by impairing β-cell function, and hepatic insulin sensitivity predicts the development of IGT/T2D over time.
引用
- Cropano C, Santoro N, Groop L, et al. The rs7903146 Variant in the TCF7L2 Gene Increases the Risk of Prediabetes/Type 2 Diabetes in Obese Adolescents by Impairing β-Cell Function and Hepatic Insulin Sensitivity. Diabetes Care. 2017. PMID: 28611053. doi:10.2337/dc17-0290
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。